Nukkleus receives Nasdaq delisting notice for bid price below $1.00

T3 Defense Inc.

Closing bid price below $1.00 for 35 consecutive business days.
180-day compliance period ends November 4, 2024 to regain compliance.
Must have closing bid of $1.00 for 10 consecutive business days to cure.
If not cured, may be eligible for second 180-day period if other listing standards met.
Company monitoring and considering options but no assurance of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

T3 Defense Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 6, 2024, Nukkleus Inc. (the “Company”) received notice from The Nasdaq Stock Market (“Nasdaq”) that the closing bid price for the Company’s common stock had been below $1.00 per share for the previous 35 consecutive business days, and that the Company is therefore not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Rule”). Nasdaq’s notice has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Capital Market. The notice indicates that the Company will h

View on SEC.gov

97 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

T3 Defense Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-040648

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.